>fig|379.114.peg.5374 NAD(P)H oxidoreductase YRKL (EC 1.6.99.-) @ Putative NADPH-quinone reductase (modulator of drug activity B) @ Flavodoxin 2
ATGAGAGTTGTCGTCCTTCACTCGCATCCGGTCGAGGAAAGCTACGGCAAGGCGCTTTACAAACAAACGCTGGAAAGCCTTCGCAAAGCCGGTCACGAGGTGGATGCCTGCGATCTCTATGCCGAGGAATTCGATCCCGTTCTCTCACGCCACGACCGGCTCGCCTATCACCACTATCCCGGCAATACCGCGCTGGTGAAGCCCTATGTCGATCGGCTGAAACAGGCCGAAGGGCTGGTGCTGGTGACGCCTGTCTGGAATTTTGGGTTCCCGGCAATCCTCAAAGGCTATTTCGATCGCGTCTGGCTCCCGGGCGTCTCTTTTGAACTTGTCGACGGCAAGGTGGAATCTAGGCTACGCCATATCACGAAGCTCGCCGCCGTACTGACCTACGGAGCAACCCCATTCCGCGCCTTCGTGGCCGGTAATCCACCGAAGAGGATCGTCAAGCGCGTGCTGCGAGCGCAGATCAATCCACTGCGGCCGGTCACCTTCCTTGCCCATTACGACATGAACAATTGCACGCCTGAAACGCGGGCCCGGTTTCTGGAAAAGGTGCAGATGGCGATGGAACGGTTCTGA
>fig|379.140.peg.2167 NAD(P)H oxidoreductase YRKL (EC 1.6.99.-) @ Putative NADPH-quinone reductase (modulator of drug activity B) @ Flavodoxin 2
ATGAACGTTCTCGTCCTTCATTCGCACCCGGTTGAGGAAAGTTACGGCAAGGCGCTTTACAAACAGACGCTGGATAGCCTTGAGAAAGCCGGCCATGCGGTTGATGCCTGCGATCTCTATGCCGAGAAATTCGACCCCGTGCTCACCCGCCGCGACCGGCTCAGCTATCACGACTATCCCGCCAATTCTGATCTGGTGAAACCCTATGTCGAGCGGCTGAAGCGGGCCGAGGGCCTGGTGCTGGTGACGCCGATCTGGAATTTCGGGTTCCCAGCGATCCTGAAGGGCTATTTCGATCGCGTCTGGCTCCCGGGTGTTTCCTTCGACCTCGTCGACGGCAAGGTGGAATCGCGGCTTCGCCATATCAGGAAGCTCGCCGCCGTTCTGACATACGGCGCCACGCCGTTTCGCGCCTTCGCCGCCGGCAATCCGCCGAAGAAGATTGTCAAACGTGTGCTGAGGGCACAGATCAATCCCCTAAGGCCGGTCACCTTTCTTGCGCATTACGACATGAACAATTGCACCGCGGAAACTCGAGCCAAGTTTCTGGAAAAGGTGAAGACGGCGATGGAGCGGTTCTAG
